Fig. 1 | Scientific Reports

Fig. 1

From: Efficacy of measuring lysophosphatidylcholine levels in human cerebrospinal fluid to differentiate myelopathy from cauda equina syndrome

Fig. 1

Concentrations of LPC species in the CSF of the CES, myelopathy, and control groups. The differences were evaluated using the Kruskal–Wallis test, followed by Benjamini–Krieger–Yekutieli two-stage false discovery rate correction as a post hoc test. Adjusted P value (q) of < 0.05 was considered to indicate significance.

Back to article page